The Role of QSAR and Virtual Screening Studies in Type 2 Diabetes Drug Discovery

被引：6

作者：

Pantaleao, Simone Q. ^{[1
]}

Fujii, Drielli G. V. ^{[2
]}

Maltarollo, Vinicius G. ^{[3
]}

Silva, Danielle da C. ^{[1
]}

Trossini, Gustavo H. G. ^{[2
]}

Weber, Karen C. ^{[4
]}

Scott, Luis P. B.

Honorio, Kathia M. ^{[1
,5
]}

机构：

[1] Fed Univ ABC, BR-09210170 Santo Andre, SP, Brazil

[2] Univ Sao Paulo, Fac Pharmaceut Sci, Dept Pharm, BR-05508000 Sao Paulo, SP, Brazil

[3] Univ Fed Minas Gerais, Fed Univ, Fac Pharm, Dept Pharmaceut Prod, BR-31270901 Belo Horizonte, MG, Brazil

[4] Univ Fed Paraiba, Dept Chem, BR-13083970 Joao Pessoa, Paraiba, Brazil

[5] Univ Sao Paulo, Sch Arts Sci & Humanities, BR-03828000 Sao Paulo, SP, Brazil

来源：

MEDICINAL CHEMISTRY | 2017年 / 13卷 / 08期

基金：

巴西圣保罗研究基金会;

关键词：

Biological targets; computational chemistry; diabetes; drug design; QSAR; virtual screening; ALPHA-GLUCOSIDASE INHIBITORS; INCREMENTAL CONSTRUCTION ALGORITHM; MOLECULAR DOCKING; DPP-4; INHIBITORS; DESIGN STRATEGIES; SGLT2; ACCURATE DOCKING; CHANNEL OPENERS; LIGAND DOCKING; 3D QSAR;

D O I：

10.2174/1573406413666170522152102

中图分类号：

R914 [药物化学];

学科分类号：

100701 ;

摘要：

Background: Due to the increasing number of diabetes cases worldwide, there is an international concern to provide even more effective treatments to control this condition. Methods: This review brings together a selection of studies that helped to broaden the comprehension of various biological targets and associated mechanisms involved in type 2 diabetes mellitus. Results: Such studies demonstrated that QSAR techniques and virtual screenings have been successfully employed in drug design projects. Conclusions: Therefore, the main goal of this review is to give the state-of-art for the development of new drugs for the treatment of type 2 diabetes mellitus and to evaluate how computational tools, such as virtual screening and 3D-QSAR, can aid the development of new drugs with reduced adverse side effects.

引用

页码：706 / 720

页数：15

共 50 条

[21] The compromise of virtual screening and its impact on drug discovery
Slater, Olivia
Kontoyianni, Maria
EXPERT OPINION ON DRUG DISCOVERY, 2019, 14 (07) : 619 - 637
[22] Virtual Screening Strategies in Drug Discovery: A Critical Review
Lavecchia, A.
Di Giovanni, C.
CURRENT MEDICINAL CHEMISTRY, 2013, 20 (23) : 2839 - 2860
[23] Algorithms for Ligand based Virtual Screening in Drug Discovery
Babaria, Khushboo
Das, Shubhankar
Ambegaokar, Sanya
Palivela, Hemant
PROCEEDINGS OF THE 2015 INTERNATIONAL CONFERENCE ON APPLIED AND THEORETICAL COMPUTING AND COMMUNICATION TECHNOLOGY (ICATCCT), 2015, : 862 - 866
[24] Perspectives on current approaches to virtual screening in drug discovery
Muegge, Ingo
Bentzien, Jorg
Ge, Yunhui
EXPERT OPINION ON DRUG DISCOVERY, 2024, 19 (10) : 1173 - 1183
[25] MEDI 267-Virtual screening for drug discovery
Joseph-McCarthy, Diane
ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2008, 236
[26] Virtual screening in structure-based drug discovery
Barril, X
Hubbard, RE
Morley, SD
MINI-REVIEWS IN MEDICINAL CHEMISTRY, 2004, 4 (07) : 779 - 791
[27] BEAR, a Novel Virtual Screening Methodology for Drug Discovery
Degliesposti, Gianluca
Portioli, Corinne
Parenti, Marco Daniele
Rastelli, Giulio
JOURNAL OF BIOMOLECULAR SCREENING, 2011, 16 (01) : 129 - 133
[28] HPC Cloud Technologies for Virtual Screening in Drug Discovery
Dolezal, Rafael
Sobeslav, Vladimir
Hornig, Ondrej
Balik, Ladislav
Korabecny, Jan
Kuca, Kamil
Intelligent Information and Database Systems, Pt II, 2015, 9012 : 440 - 449
[29] Modern 2D QSAR for drug discovery
Lewis, Richard A.
Wood, David
WILEY INTERDISCIPLINARY REVIEWS-COMPUTATIONAL MOLECULAR SCIENCE, 2014, 4 (06) : 505 - 522
[30] Discovery of a novel family of SARS-CoV protease inhibitors by virtual screening and 3D-QSAR studies
Tsai, Keng-Chang
Chen, Shih-Yuan
Liang, Po-Huang
Lu, I-Lin
Mahindroo, Neeraj
Hsieh, Hsing-Pang
Chao, Yu-Sheng
Liu, Lincoln
Liu, Donald
Lien, Wei
Lin, Thy-Hou
Wu, Su-Ying
JOURNAL OF MEDICINAL CHEMISTRY, 2006, 49 (12) : 3485 - 3495

← 1 2 3 4 5 →